Mancuso, Pietro http://orcid.org/0000-0001-7079-9848
Chen, Chen
Kaminski, Rafal http://orcid.org/0000-0001-8827-6658
Gordon, Jennifer
Liao, Shuren
Robinson, Jake A.
Smith, Mandy D.
Liu, Hong
Sariyer, Ilker K.
Sariyer, Rahsan
Peterson, Tiffany A.
Donadoni, Martina
Williams, Jaclyn B.
Siddiqui, Summer
Bunnell, Bruce A.
Ling, Binhua http://orcid.org/0000-0002-2259-8889
MacLean, Andrew G. http://orcid.org/0000-0002-0356-0674
Burdo, Tricia H. http://orcid.org/0000-0002-4224-7381
Khalili, Kamel http://orcid.org/0000-0002-6819-5217
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS104016, R01NS104016, R01NS104016)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (R56AI143647)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R56AI143647)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (P30092177)
Article History
Received: 17 February 2020
Accepted: 16 October 2020
First Online: 27 November 2020
Competing interests
: K.K. and R.K. are named inventors on patents that cover the viral gene editing technology that is the subject of this article. In addition to the foregoing interests, K.K. is a co-founder, board member, scientific advisor, and holds equity in Excision Biotherapeutics, a biotech start-up that has licensed the viral gene editing technology from Temple University for commercial development and clinical trials. T.H.B. and J.G. have equity in Excision Biotherapeutics and members of the Scientific Advisory Board. All other authors have no interests to disclose.